89 related articles for article (PubMed ID: 19259053)
1. Bcl-2 as a prognostic factor for survival in small-cell lung cancer.
Ilievska Poposka B; Smickova S; Jovanovska Crvenkovska S; Zafirovska Ivanovska B; Stefanovski T; Petrusevska G
Prilozi; 2008 Dec; 29(2):281-93. PubMed ID: 19259053
[TBL] [Abstract][Full Text] [Related]
2. Bcl-2 expression as a predictor of chemosensitivities and survival in small cell lung cancer.
Takayama K; Ogata K; Nakanishi Y; Yatsunami J; Kawasaki M; Hara N
Cancer J Sci Am; 1996; 2(4):212-6. PubMed ID: 9166534
[TBL] [Abstract][Full Text] [Related]
3. Metabolic activity on [18f]-fluorodeoxyglucose-positron emission tomography/computed tomography and glucose transporter-1 expression might predict clinical outcomes in patients with limited disease small-cell lung cancer who receive concurrent chemoradiation.
Lee J; Kim JO; Jung CK; Kim YS; Yoo IeR; Choi WH; Jeon EK; Hong SH; Chun SH; Kim SJ; Kim YK; Kang JH
Clin Lung Cancer; 2014 Mar; 15(2):e13-21. PubMed ID: 24368212
[TBL] [Abstract][Full Text] [Related]
4. The downregulation of Bcl-xL/Bcl-2-associated death promoter indicates worse outcomes in patients with small cell lung carcinoma.
Yu Y; Zhong Z; Guan Y
Int J Clin Exp Pathol; 2015; 8(10):13075-82. PubMed ID: 26722503
[TBL] [Abstract][Full Text] [Related]
5. Survival in small cell lung carcinoma is independent of Bcl-2 expression.
Maitra A; Amirkhan RH; Saboorian MH; Frawley WH; Ashfaq R
Hum Pathol; 1999 Jun; 30(6):712-7. PubMed ID: 10374782
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for survival in extensive stage small cell lung cancer (ED-SCLC): the importance of smoking history, socioeconomic and marital statuses, and ethnicity.
Ou SH; Ziogas A; Zell JA
J Thorac Oncol; 2009 Jan; 4(1):37-43. PubMed ID: 19096304
[TBL] [Abstract][Full Text] [Related]
7. ERCC1 and Ki67 in small cell lung carcinoma and other neuroendocrine tumors of the lung: distribution and impact on survival.
Skov BG; Holm B; Erreboe A; Skov T; Mellemgaard A
J Thorac Oncol; 2010 Apr; 5(4):453-9. PubMed ID: 20104194
[TBL] [Abstract][Full Text] [Related]
8. High expression of oncoprotein DEK predicts poor prognosis of small cell lung cancer.
Wang X; Lin L; Ren X; Lin Z; Li Z; Li C; Jin T
Int J Clin Exp Pathol; 2014; 7(8):5016-23. PubMed ID: 25197373
[TBL] [Abstract][Full Text] [Related]
9. Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis.
Yaren A; Oztop I; Kargi A; Ulukus C; Onen A; Sanli A; Binicier O; Yilmaz U; Alakavuklar M
Int J Clin Pract; 2006 Jun; 60(6):675-82. PubMed ID: 16805752
[TBL] [Abstract][Full Text] [Related]
10. Expression of bcl-2 protein in non-small cell lung cancer: correlation with clinicopathology and patient survival.
Laudanski J; Chyczewski L; Niklińska WE; Kretowska M; Furman M; Sawicki B; Nikliński J
Neoplasma; 1999; 46(1):25-30. PubMed ID: 10355530
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of immunohistochemical staining of p53, bcl-2, and Ki-67 in small cell lung cancer.
Paik KH; Park YH; Ryoo BY; Yang SH; Lee JC; Kim CH; Ki SS; Kim JM; Park MJ; Ahn HJ; Choi W; Chung JH
J Korean Med Sci; 2006 Feb; 21(1):35-9. PubMed ID: 16479062
[TBL] [Abstract][Full Text] [Related]
12. Expression of Ki-67, Bcl-2, Survivin and p53 Proteins in Patients with Pulmonary Carcinoma.
Halasova E; Adamkov M; Matakova T; Vybohova D; Antosova M; Janickova M; Singliar A; Dobrota D; Jakusova V
Adv Exp Med Biol; 2013; 756():15-21. PubMed ID: 22836614
[TBL] [Abstract][Full Text] [Related]
13. Expression of bcl-2 protein is associated with shorter survival in nonsmall cell lung carcinoma.
Huang CI; Neuberg D; Johnson BE; Wei JY; Christiani DC
Cancer; 2003 Jul; 98(1):135-43. PubMed ID: 12833466
[TBL] [Abstract][Full Text] [Related]
14. NAD(P)H:quinone oxidoreductase-1 overexpression predicts poor prognosis in small cell lung cancer.
Cui X; Jin T; Wang X; Jin G; Li Z; Lin L
Oncol Rep; 2014 Dec; 32(6):2589-95. PubMed ID: 25231218
[TBL] [Abstract][Full Text] [Related]
15. The prognostic factors in the elderly patients with small cell lung cancer: a retrospective analysis from a single cancer institute.
Liu S; Guo H; Kong L; Li H; Zhang Y; Zhu H; Yu J
Int J Clin Exp Pathol; 2015; 8(9):11033-41. PubMed ID: 26617821
[TBL] [Abstract][Full Text] [Related]
16. Significance of programmed cell death-ligand 1 expression and its association with survival in patients with small cell lung cancer.
Ishii H; Azuma K; Kawahara A; Yamada K; Imamura Y; Tokito T; Kinoshita T; Kage M; Hoshino T
J Thorac Oncol; 2015 Mar; 10(3):426-30. PubMed ID: 25384063
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in the apoptotic pathway gene BCL-2 and survival in small cell lung cancer.
Knoefel LF; Werle-Schneider G; Dally H; Müller PJ; Edler L; Bartsch H; Tuengerthal S; Heussel CP; Reinmuth N; Thomas M; Risch A
J Thorac Oncol; 2011 Jan; 6(1):183-9. PubMed ID: 21107291
[TBL] [Abstract][Full Text] [Related]
19. Bcl-2 and β1-integrin predict survival in a tissue microarray of small cell lung cancer.
Lawson MH; Cummings NM; Rassl DM; Vowler SL; Wickens M; Howat WJ; Brenton JD; Murphy G; Rintoul RC
Br J Cancer; 2010 Nov; 103(11):1710-5. PubMed ID: 21063403
[TBL] [Abstract][Full Text] [Related]
20. Bcl-2 protein expression correlates with better prognosis in patients with advanced non-small cell lung cancer.
Shibata Y; Hidaka S; Tagawa Y; Nagayasu T
Anticancer Res; 2004; 24(3b):1925-8. PubMed ID: 15274378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]